RxDoctor Payments Data

Irina Dariychuk

Registered Nurse · Antelope, CANPI 1477871630

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $217,200 of the $242,283 with a category attached, or 89.6%. Every reported general payment came from a single manufacturer, AbbVie. Reporting peaked in 2023 at $113,804 and has fallen 52.6% since, to $53,950 in 2025. Among registered nurse clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$242,283in general payments, 2019–2025

Across 419 payments — averaging $578.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$242K

What the payments were for

  • Speaking & faculty fees$217,20090%
  • Travel & lodging$14,7326%
  • Food & beverage$10,3514%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)419$242,283

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$242,283 in reported general payments places this provider in the 95th percentile of 533 registered nurse providers in California.

See all registered nurse providers in California →

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProgesteroneProgesterone, Micronized11$669

Paid to pharmacies, not to this prescriber.

Other registered nurse in Antelope

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →